AUDREY PILKINGTON: Open Payments
NPI 1124720107 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,483 in 20 payments from 10 companies in 2025. Trend: 2023 $102 · 2024 $138 · 2025 $1,483
Food & beverage: $1,292Education: $191
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $523 |
| Galderma Laboratories, L.P. | 2 | $294 |
| Organon LLC | 1 | $150 |
| UCB, Inc. | 1 | $137 |
| LEO Pharma Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $95 |
| ABBVIE INC. | 2 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: DUPIXENT, NEMLUVIO, VTAMA, Bimzelx, ANZUPGO, TREMFYA, RINVOQ, LEQVIO.
Industry payments across TX — which companies pay providers there.
